Landri C. Hardcastle

Landri Hardcastle practices at Rheumatology and Osteoporosis Specialists, AMC in Shreveport, Louisiana.

Landri Hardcastle's NPI, 1326826629, was assigned on September 18, 2023.

Landri Hardcastle's primary practice is Rheumatology and Osteoporosis Specialists, AMC, at 820 Jordan St, Shreveport, LA 71101 in Caddo Parish. The practice phone is (318) 221-0399.

Landri Hardcastle's primary practice is Rheumatology and Osteoporosis Specialists, AMC in Shreveport, Louisiana. Landri Hardcastle is also affiliated with Willis Knighton North. The medical group on file is Rheumatology and Osteoporosis Specialists. Dmand AI also links Landri Hardcastle to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Landri Hardcastle practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Landri Hardcastle's primary specialty in the NPI Registry, under taxonomy code 363A00000X.

CMS data shows 76 Medicare services from Landri Hardcastle across 4 procedure codes in 2024, for 65 Medicare patients. Medicare paid $3,583 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Landri Hardcastle in 2024. The largest group is 75 to 84, with 26 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Landri Hardcastle's median patient age at 73, with 76% women.

In 2024, Landri Hardcastle wrote 267 Medicare Part D claims for 167 patients. 90% of them were for generic drugs. CMS names the drug for 171 of them, across 4 drugs with 11 or more claims each, at $6,869 in total drug cost.

Landri Hardcastle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 167 general payments to Landri Hardcastle from 18 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $785.